Skip to main content
. 2017 May 2;8(33):54604–54615. doi: 10.18632/oncotarget.17554

Table 4. Multivariate analyses.

A
Parameter HR 95% confidence interval p-Value
min max
pT category 1.397 0.98 1.99 0.064
Lymph node metastasis 1.942 1.199 3.147 0.007
Grading 1.046 0.634 1.724 0.86
Age 4.093 2.418 6.929 0.001
LC3B dot-like staining 0.599 0.376 0.954 0.031
B
Parameter HR 95% confidence interval p-Value
min max
pT category 1.355 0.95 1.933 0.094
Lymph node metastasis 2.088 1.284 3.396 0.003
Grading 1.071 0.645 1.777 0.792
Age 4.084 2.409 6.921 0.001
p62 dot-like/cytoplasmic 0.507 0.285 0.902 0.021
C
Parameter HR 95% confidence interval p-Value
min max
pT category 1.408 0.983 2.016 0.062
Lymph node metastasis 1.87 1.151 3.037 0.011
Grading 1.058 0.641 1.749 0.825
Age 4.024 2.374 6.82 0.001
LC3B dot-like/p62 dot-like-cytoplasmic 0.751 0.607 0.928 0.008

A) model including LC3B dot-like immunohistochemical staining; B) model including p62 dot-like-cytoplasmic immunohistochemical staining; C) model including the combination of LC3B dot-like/p62 dot-like-cytoplasmic immunohistochemical staining.